(1 - 6 from 9
)
Drugmaker Shire bids $30 billion for Baxter spin-off Baxalta | Reuters
www.reuters.com
Drugmaker Shire said on Tuesday it was seeking to buy Baxalta , a company spun-off by Baxter International last month, for $30 billion to forge the leading...
With Shire takeover bid looming, Baxalta CEO offers plan for growth -...
www.bostonglobe.com
Ludwig N. Hantson outlined a plan that he said would enable his company to realize the same value of the bid in the next six to 12 months.
Baxalta rejects Shire’s $30 billion unsolicited bid - The Boston Globe
www.bostonglobe.com
The board of Baxalta said the offer significantly undervalues the company and “its attractive prospects for growth and value creation.”
Shire seen having to raise offer price to get Baxalta to negotiating...
www.ibtimes.co.uk
Baxalta's Ludwig Hantson reiterates proposal is 'wholly inadequate'.
sorted by relevance / date